ALDEYRA THERAPEUTICS, INC.

Profile

Company Names

ALDEYRA THERAPEUTICS, INC.
ALDEXA THERAPEUTICS, INC.

Addresses

131 HARTWELL AVENUE, SUITE 320, LEXINGTON, MA 02421

15 NEW ENGLAND EXECUTIVE PARK, BURLINGTON, MA 01803

Phone Numbers

781-761-4904
617-513-9882

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$24,585,223.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2019-01-28 
$10,000,000.00 
$25,000,000.00 
$15,000,000.00 
Equity 
3
2015-01-21 
$1,999,997.00 
$4,009,513.00 
$2,009,516.00 
Equity 
2
2015-01-14 
$7,791,560.00 
$18,365,820.00 
$10,574,260.00 
Equity 
1
2012-12-20 
$4,793,666.00 
$8,787,906.00 
$3,994,240.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TODD 
 
BRADY 
EXECUTIVE OFFICER, DIRECTOR
NOVADIGM THERAPEUTICS INC   |  ASMACURE, INC.   |  EVOKE PHARMA INC   |  SEBACIA, INC.   |  ALDEXA THERAPEUTICS, INC.   |  RX GREEN SOLUTIONS LLC   |  ONCOBIOLOGICS, INC.   |  TYROGENEX, INC.   |  THERABRON THERAPEUTICS, INC.   |  AVIDITY BIOSCIENCES LLC   |  GENO LLC   |  ALDEYRA THERAPEUTICS, INC.   |  AVIDITY BIOSCIENCES, INC.   |  VERO BIOTECH INC.   |  HYPERFRAME INC.
TODD 
C. 
BRADY 
EXECUTIVE OFFICER, DIRECTOR
PARINGENIX INC   |  CANTEX PHARMACEUTICALS, INC.   |  ALDEYRA THERAPEUTICS, INC.   |  ONCOBIOLOGICS, INC.
BEN 
 
BRONSTEIN 
DIRECTOR
EXITHERA PHARMACEUTICALS LLC   |  VEDANTRA PHARMACEUTICALS, INC.   |  ALDEXA THERAPEUTICS, INC.   |  ALDEYRA THERAPEUTICS, INC.   |  CLEVELAND DIAGNOSTICS, INC.
GERALD 
 
CAGLE 
EXECUTIVE OFFICER, DIRECTOR
ALDEXA THERAPEUTICS, INC.   |  AERIE PHARMACEUTICALS INC   |  GRAYBUG LLC   |  GRAYBUG, INC.   |  GRAYBUG VISION, INC.   |  NACUITY PHARMACEUTICALS, INC.
DAVID 
L. 
CLARK 
EXECUTIVE OFFICER
ALDEYRA THERAPEUTICS, INC.   |  CARSNOOP INC.
C. BOYD 
 
CLARKE 
DIRECTOR
PALKION INC   |  RIB X PHARMACEUTICALS INC   |  RIB-X PHARMACEUTICALS, INC.   |  ALDEYRA THERAPEUTICS, INC.
C.BOYD 
 
CLARKE 
DIRECTOR
ALDEYRA THERAPEUTICS, INC.
RICHARD 
 
DOUGLAS 
DIRECTOR
BLACK DIAMOND STRUCTURED OPPORTUNITIES LTD   |  BLACK DIAMOND RELATIVE VALUE LTD   |  BLACK DIAMOND LTD   |  BLACK DIAMOND ARBITRAGE LTD   |  DOUBLE BLACK DIAMOND LTD   |  SEGREGATED PORTFOLIO C, A SEGREGATED PORTFOLIO OF MAGNETAR SPC   |  MAGNETAR GLOBAL EVENT DRIVEN FUND LTD   |  BLACK DIAMOND THEMATIC LTD.   |  BLACK DIAMOND RELATIVE VALUE LTD.   |  BLACK DIAMOND LTD.   |  BLACK DIAMOND ARBITRAGE LTD.   |  DOUBLE BLACK DIAMOND LTD.   |  BLACK DIAMOND SRI LTD.   |  ALDEYRA THERAPEUTICS, INC.
JOHN 
 
DOWLING 
DIRECTOR
ALDEXA THERAPEUTICS, INC.
MARTIN 
J. 
JOYCE 
DIRECTOR
ALDEYRA THERAPEUTICS, INC.   |  ASCENDANCE BIOTECHNOLOGY, INC.
STEPHEN 
 
MACHATHA 
EXECUTIVE OFFICER
ALDEYRA THERAPEUTICS, INC.
DAVID 
 
MCMULLIN 
EXECUTIVE OFFICER
ALDEYRA THERAPEUTICS, INC.   |  SILVER BOW MINING CORP.
GARY 
 
PHILLIPS 
DIRECTOR
DEBT ACQUISITION ASSOCIATES III, LLC   |  ALDEXA THERAPEUTICS, INC.   |  ALDEYRA THERAPEUTICS, INC.   |  GLOBAL COOLING, INC.   |  ENVISIA THERAPEUTICS, INC.   |  AMLI-ALLIANZ DAVIE REIT, LP   |  AMLI-ALLIANZ 1400 HI LINE DRIVE REIT, LP   |  TRITON CONSOLIDATED, INC.   |  1800 M STREET REIT, LP   |  FOREFRONT SOLUTIONS, INC.   |  AKMAZO CAPITAL FUND I, L.P.   |  AKMAZO CO-INVESTMENT A, LLC
JOSHUA 
 
REED 
EXECUTIVE OFFICER
MAROLINA OUTDOOR INC   |  ALDEYRA THERAPEUTICS, INC.
JESSE 
I. 
TREU 
DIRECTOR
ALTEA THERAPEUTICS CORP   |  DP VIII ASSOCIATES, L.P.   |  DOMAIN PARTNERS VIII, L.P.   |  SOMAXON PHARMACEUTICALS, INC.   |  COLUCID PHARMACEUTICALS, INC.   |  VERACYTE, INC.   |  ALDEYRA THERAPEUTICS, INC.
STEPHEN 
 
TULIPANO 
EXECUTIVE OFFICER
ALDEYRA THERAPEUTICS, INC.
NEAL 
 
WALKER 
DIRECTOR
VICEPT THERAPEUTICS, INC.   |  ACLARIS THERAPEUTICS, INC.   |  SEBACIA, INC.   |  ALEXAR THERAPEUTICS, INC.   |  ACTIVE PROTECTIVE TECHNOLOGIES, INC.   |  ALDEYRA THERAPEUTICS, INC.   |  ZOOMI, INC.   |  RALEXAR THERAPEUTICS, INC.   |  MYOTA, INC.
ASISH 
 
XAVIER 
DIRECTOR
CELLADON CORP   |  AQUINOX PHARMACEUTICALS (USA) INC   |  AQUINOX PHARMACEUTICALS INC   |  ISCIENCE INTERVENTIONAL CORP   |  ISCIENCE INTERVENTIONAL CORP   |  CATALYST BIOSCIENCES INC   |  GENOCEA BIOSCIENCES, INC.   |  ALDEXA THERAPEUTICS, INC.   |  E-SCAPE BIO, INC.   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  APOGEN BIOTECHNOLOGIES, INC.   |  RODEO THERAPEUTICS CORP   |  PRONIRAS CORP   |  MAGNOLIA NEUROSCIENCES CORP   |  VIACYTE INC.   |  ADICET BIO, INC.   |  ESCAPE BIO, INC.   |  IMMPACT BIO USA INC.   |  PAIGE.AI, INC.   |  SONOTHERA, INC.   |  BRIGHT PEAK THERAPEUTICS, INC.
SCOTT 
 
YOUNG 
EXECUTIVE OFFICER
ALDEYRA THERAPEUTICS, INC.   |  JHI ASSOCIATES INC.   |  TRANSMIT.LIVE, LLC   |  INTERRA COPPER CORP.
SCOTT 
L. 
YOUNG 
EXECUTIVE OFFICER
ALDEYRA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-02-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-01-28 
2015-02-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-01-21 
2015-01-29
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-01-14 
2013-01-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#